Shares of Star Scientific, Inc. (Nasdaq: CIGX) plunged almost 50% today on the decision issued today by the Federal Circuit Court of Appeals. Star Scientific, Inc. so far lost its patent-infringement trial against Reynolds American Inc. A few quick facts: Star Scientific has numerous valid patents, their CigRX is a proven working product, Anatabloc launch […]
Peregrine Pharmaceuticals (PPHM): Evaluation of Phase II Trials
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) reported today 20.7 month median overall survival results based on Phase II study of bavituximab in combination with docetaxel in patients with metastatic breast cancer. PPHM has been traded 3 fold of its 10day average volume as of 10:15 a.m. EST Peregrine Pharmaceuticals Inc. 14282 Franklin Avenue Tustin, CA 92780 United […]
China TechFaith Wireless Communication Technology Limited (CNTF): still room to grow
China TechFaith Wireless Communication Technology Limited (CNTF) today announced unaudited financial results for the second quarter ended June 30, 2011. Even with financials are below estimate, company has enough room to grow. Yesterday, TechFaith Wireless Technology announced that it will launch a new mobile social media solution in China called “17Talk”, along with “17Store”, through […]
Stereotaxis Inc. (STXS): Impending Bounce Play
Stereotaxis Inc. (Nasdaq: STXS) announced Monday after-hours that its loss in the second quarter widened to $9.7 million, compared with a loss of $3.9 million in the second quarter of 2010. The St. Louis medical device maker reported revenue of $11.6 million for the quarter ended June 30, down 23 percent from $15 million a […]
OCLS & PWAV: Financial Results
Oculus Innovative Sciences, Inc. (OCLS) & Powerwave Technologies, Inc. (PWAV) today announced financial results for the last quarter. These financial achievements should have a positive impact on both stocks even with current stock market conditions. Oculus Innovative Sciences Reports Record First Quarter Financial Results PETALUMA, Calif. , Aug. 4, 2011 (GLOBE NEWSWIRE) — Oculus Innovative […]
Sun Healthcare Group Inc. (SUNH): market over-reaction on planned Medicare’s cut.
On Friday Medicare announced plan to reduce payments to skilled-nursing facilities by 11.1% for fiscal 2012, cutting $3.87 billion out of the spending plan. Sun Healthcare Group Inc. (SUNH) has been beaten down for an over 56% on this Medicare’s update. With $75M market cap (as of today) & ~$2B in revenues Sun Healthcare Group […]
CytRx Corporation (CYTR): profiting of Nasdaq’s dilutor
CytRx Corporation (CYTR) announced public offering of 39,200,000 shares of common stock and warrants to purchase up to 39,200,000 shares of common stock at a combined public offering price of $0.52 per share and related warrant for gross proceeds of approximately $20.4 million. CytRx’s stock has years of history of under performing based on the […]
Marshall Edwards, Inc.(MSHL): Pre-Clinical Study Announcement
Marshall Edwards, Inc.(Nasdaq:MSHL) announced the publication of results from a pre-clinical study of its investigational compound NV-128, that’s showing activity in chemotherapy-resistant ovarian cancer stem cells. MSH stock gained over 130% on 150X 10day average volume as of 10 a.m. on July 27th. Marshall Edwards Announces Publication of Pre-Clinical Study Showing Activity in Chemotherapy-Resistant Ovarian […]
Seven Arts Pictures PLC (SAPX): settled for multi-gains
Seven Arts Pictures PLC (NASDAQ:SAPX) entered into production agreement with Prodigy Pictures, Inc. to produce and distribute the highly-anticipated motion picture “Neuromancer,” based on the novel by William Gibson. As of 12:30 p.m. SAPX traded over 540K shares vs 620K free trading & settled for the multi-percentage gains in up-coming sessions. Seven Arts Pictures PLC […]
Transcept Pharmaceuticals, Inc.(Nasdaq: TSPT ): Bounce on Low Float Count
Transcept Pharmaceuticals, Inc.(Nasdaq: TSPT ) plummeted today to a year low. Pharmaceutical company said it expects a second rejection letter from the U.S. health regulator regarding its sleep disorder drug. Transcept expects complete response letter on Intermezzo NDA Transcept Pharmaceuticals announced that it expects to receive a complete response letter from the U.S. FDA regarding […]